Haloprogin
From Self-sufficiency
| File:Haloprogin.png | |
| Systematic (IUPAC) name | |
|---|---|
|
1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene | |
| Clinical data | |
| Routes of administration | Topical |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 777-11-7 |
| ATC code | D01AE11 (WHO) |
| PubChem | CID 3561 |
| DrugBank | APRD01011 |
| Chemical data | |
| Formula | C9H4Cl3IO |
| Molar mass | 361.39[[Script error: No such module "String".]] |
| Physical data | |
| Melting point | 113.5 °C (236.3 °F) |
| (verify) | |
Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.
Action
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over the counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[1]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]
References
- ↑ "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17.
- ↑ "Haloprogin". DrugBank. University of Alberta. Nov 06, 2006. Retrieved 2007-02-17. Check date values in:
|date=(help)
| 50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
| 40px | This dermatologic drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- CS1 errors: dates
- Missing redirects
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Antifungals
- Organoiodides
- Organochlorides
- Alkynes
- Antiinfective agent stubs
- Dermatologic drug stubs
- 2Fix
